The type segmentation classifies catheters into single‑use, reusable, drug‑eluting, and imaging‑enabled families, each with distinct sub‑categories that affect cost structure and adoption rates. Single‑use catheters, the largest segment, include standard, hydrophilic‑coated, and pre‑filled variants, together representing approximately 55 % of market value due to infection‑control mandates. Reusable systems—comprising sterilizable stainless‑steel, polymeric, and hybrid designs—capture roughly 20 % as institutions seek long‑term cost efficiencies. Drug‑eluting catheters, subdivided into anti‑restenotic, antimicrobial, and chemotherapeutic delivery models, hold a 15 % share, reflecting niche adoption in high‑risk vascular and oncologic procedures. Imaging‑enabled catheters, featuring integrated ultrasound or optical coherence tomography, account for the remaining 10 % and are expanding in complex interventional workflows. These type‑based allocations collectively define the market taxonomy and illustrate how functional differentiation drives revenue distribution across the Minimally Invasive Medical Catheter Customized Solution market.